Cargando…
P547: UPFRONT INTENSIVE TREATMENT ANALYSIS OF THE ITALIAN COHORT STUDY ON FLT3-MUTATED AML PATIENTS (FLAM): THE IMPACT OF A FLT3 INHIBITOR ADDITION TO STANDARD CHEMOTHERAPY IN THE REAL-LIFE SETTING
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428994/ http://dx.doi.org/10.1097/01.HS9.0000969096.68540.54 |
| _version_ | 1785090604556877824 |
|---|---|
| author | Nanni, Jacopo Mulè, Antonino Audisio, Ernesta Paola Martelli, Maria Scappini, Barbara Petracci, Elisabetta Valli, Irene Azzali, Irene Zingaretti, Chiara Benedetta Giannini, Maria Sica, Simona Cambò, Benedetta Candoni, Anna Lunghi, Monia Albano, Francesco Olivieri, Attilio Fracchiolla, Nicola Matteo Rigolin, Gian Bernardi, Massimo Romani, Claudio Todisco, Elisabetta Gigli, Federica Bocchia, Monica Cilloni, Daniela DI Renzo, Nicola Vallisa, Daniele Maria Mianulli, Anna Cignetti, Alessandro Lanza, Francesco Robustelli, Valentina Simonetti, Giorgia Teresa Bochicchio, Maria Marconi, Giovanni Flam Collaborative Group, The Papayannidis, Cristina Martinelli, Giovanni |
| author_facet | Nanni, Jacopo Mulè, Antonino Audisio, Ernesta Paola Martelli, Maria Scappini, Barbara Petracci, Elisabetta Valli, Irene Azzali, Irene Zingaretti, Chiara Benedetta Giannini, Maria Sica, Simona Cambò, Benedetta Candoni, Anna Lunghi, Monia Albano, Francesco Olivieri, Attilio Fracchiolla, Nicola Matteo Rigolin, Gian Bernardi, Massimo Romani, Claudio Todisco, Elisabetta Gigli, Federica Bocchia, Monica Cilloni, Daniela DI Renzo, Nicola Vallisa, Daniele Maria Mianulli, Anna Cignetti, Alessandro Lanza, Francesco Robustelli, Valentina Simonetti, Giorgia Teresa Bochicchio, Maria Marconi, Giovanni Flam Collaborative Group, The Papayannidis, Cristina Martinelli, Giovanni |
| author_sort | Nanni, Jacopo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428994 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289942023-08-17 P547: UPFRONT INTENSIVE TREATMENT ANALYSIS OF THE ITALIAN COHORT STUDY ON FLT3-MUTATED AML PATIENTS (FLAM): THE IMPACT OF A FLT3 INHIBITOR ADDITION TO STANDARD CHEMOTHERAPY IN THE REAL-LIFE SETTING Nanni, Jacopo Mulè, Antonino Audisio, Ernesta Paola Martelli, Maria Scappini, Barbara Petracci, Elisabetta Valli, Irene Azzali, Irene Zingaretti, Chiara Benedetta Giannini, Maria Sica, Simona Cambò, Benedetta Candoni, Anna Lunghi, Monia Albano, Francesco Olivieri, Attilio Fracchiolla, Nicola Matteo Rigolin, Gian Bernardi, Massimo Romani, Claudio Todisco, Elisabetta Gigli, Federica Bocchia, Monica Cilloni, Daniela DI Renzo, Nicola Vallisa, Daniele Maria Mianulli, Anna Cignetti, Alessandro Lanza, Francesco Robustelli, Valentina Simonetti, Giorgia Teresa Bochicchio, Maria Marconi, Giovanni Flam Collaborative Group, The Papayannidis, Cristina Martinelli, Giovanni Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428994/ http://dx.doi.org/10.1097/01.HS9.0000969096.68540.54 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Nanni, Jacopo Mulè, Antonino Audisio, Ernesta Paola Martelli, Maria Scappini, Barbara Petracci, Elisabetta Valli, Irene Azzali, Irene Zingaretti, Chiara Benedetta Giannini, Maria Sica, Simona Cambò, Benedetta Candoni, Anna Lunghi, Monia Albano, Francesco Olivieri, Attilio Fracchiolla, Nicola Matteo Rigolin, Gian Bernardi, Massimo Romani, Claudio Todisco, Elisabetta Gigli, Federica Bocchia, Monica Cilloni, Daniela DI Renzo, Nicola Vallisa, Daniele Maria Mianulli, Anna Cignetti, Alessandro Lanza, Francesco Robustelli, Valentina Simonetti, Giorgia Teresa Bochicchio, Maria Marconi, Giovanni Flam Collaborative Group, The Papayannidis, Cristina Martinelli, Giovanni P547: UPFRONT INTENSIVE TREATMENT ANALYSIS OF THE ITALIAN COHORT STUDY ON FLT3-MUTATED AML PATIENTS (FLAM): THE IMPACT OF A FLT3 INHIBITOR ADDITION TO STANDARD CHEMOTHERAPY IN THE REAL-LIFE SETTING |
| title | P547: UPFRONT INTENSIVE TREATMENT ANALYSIS OF THE ITALIAN COHORT STUDY ON FLT3-MUTATED AML PATIENTS (FLAM): THE IMPACT OF A FLT3 INHIBITOR ADDITION TO STANDARD CHEMOTHERAPY IN THE REAL-LIFE SETTING |
| title_full | P547: UPFRONT INTENSIVE TREATMENT ANALYSIS OF THE ITALIAN COHORT STUDY ON FLT3-MUTATED AML PATIENTS (FLAM): THE IMPACT OF A FLT3 INHIBITOR ADDITION TO STANDARD CHEMOTHERAPY IN THE REAL-LIFE SETTING |
| title_fullStr | P547: UPFRONT INTENSIVE TREATMENT ANALYSIS OF THE ITALIAN COHORT STUDY ON FLT3-MUTATED AML PATIENTS (FLAM): THE IMPACT OF A FLT3 INHIBITOR ADDITION TO STANDARD CHEMOTHERAPY IN THE REAL-LIFE SETTING |
| title_full_unstemmed | P547: UPFRONT INTENSIVE TREATMENT ANALYSIS OF THE ITALIAN COHORT STUDY ON FLT3-MUTATED AML PATIENTS (FLAM): THE IMPACT OF A FLT3 INHIBITOR ADDITION TO STANDARD CHEMOTHERAPY IN THE REAL-LIFE SETTING |
| title_short | P547: UPFRONT INTENSIVE TREATMENT ANALYSIS OF THE ITALIAN COHORT STUDY ON FLT3-MUTATED AML PATIENTS (FLAM): THE IMPACT OF A FLT3 INHIBITOR ADDITION TO STANDARD CHEMOTHERAPY IN THE REAL-LIFE SETTING |
| title_sort | p547: upfront intensive treatment analysis of the italian cohort study on flt3-mutated aml patients (flam): the impact of a flt3 inhibitor addition to standard chemotherapy in the real-life setting |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428994/ http://dx.doi.org/10.1097/01.HS9.0000969096.68540.54 |
| work_keys_str_mv | AT nannijacopo p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT muleantonino p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT audisioernesta p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT paolamartellimaria p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT scappinibarbara p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT petraccielisabetta p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT valliirene p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT azzaliirene p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT zingarettichiara p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT benedettagianninimaria p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT sicasimona p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT cambobenedetta p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT candonianna p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT lunghimonia p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT albanofrancesco p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT olivieriattilio p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT fracchiollanicola p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT matteorigolingian p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT bernardimassimo p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT romaniclaudio p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT todiscoelisabetta p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT giglifederica p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT bocchiamonica p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT cillonidaniela p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT direnzonicola p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT vallisadaniele p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT mariamianullianna p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT cignettialessandro p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT lanzafrancesco p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT robustellivalentina p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT simonettigiorgia p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT teresabochicchiomaria p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT marconigiovanni p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT flamcollaborativegroupthe p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT papayannidiscristina p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting AT martinelligiovanni p547upfrontintensivetreatmentanalysisoftheitaliancohortstudyonflt3mutatedamlpatientsflamtheimpactofaflt3inhibitoradditiontostandardchemotherapyinthereallifesetting |